Invasive cardiology involves diagnostic and therapeutic procedures that require the insertion of catheters or other instruments into the body, typically through blood vessels or body cavities. This approach allows for direct visualization and intervention in the cardiovascular system. Common invasive cardiology procedures include cardiac catheterization, angioplasty, and stent placement to diagnose and treat conditions such as coronary artery disease and blockages. Invasive techniques often provide more detailed information about the heart and blood vessels, enabling precise interventions. While invasive procedures can be highly effective, they carry inherent risks and may necessitate a recovery period. The expertise of interventional cardiologists is essential in performing these procedures, ensuring accurate diagnoses and appropriate interventions to improve patients' cardiovascular health.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States